Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease

Annals of Internal Medicine

Volumn 125, Issue 12, 1996, Pages 945-954

  Kroon, Abraham A ^a   Van Asten, Wim N J C ^a   Stalenhoef, Anton F H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; AORTA STENOSIS; APHERESIS; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIBIAL ARTERY;

EID: 0030447112     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-12-199612150-00001     Document Type: Article

References (54)

1. Superko HR, Krauss RM. Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management. Circulation 1994;90:1056-69.
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-9
3. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301-7.
4. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation. 1990;82:1925-31.
5. Berenson GS, Wattigney WA, Tracy RE, Newman WP 3d, Srinivasan SR, Webber LS, et al. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am J Cardiol. 1992;70:851-8.
6. Olsson AG, Ruhn G, Erikson U. The effect of serum lipid regulation on the development of femoral atherosclerosis in hyperlipidemia: a non-randomized controlled study. J Intern Med. 1990;227:381-90.
7. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LI, Campbell GS, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of Hyperlipidemias (POSCH). N Engl J Med. 1990;323:946-55.
8. Blankenhorn DH, Azen SP, Crawford DW, Nessim SA, Sanmarco ME, Selzer RH, et al. Effects of colestipol-niacm therapy on human femoral atherosclerosis. Circulation. 1991;83:438-47.
9. Agishi T, Naganuma S, Nakasato S, Kitajima K, Ota K, Ban K, et al. Treatment of arteriosclerotic obstruction by LDL adsorption. Angiology. 1993;44:222-7.
10. Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Belder R, Park JS, et al. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation. 1995;92:1758-64.
11. Blankenhorn DH, Selzer RH. Crawford DW, Barth JD, Liu C, Liu CH, et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation. 1993;88:20-8.
12. Mack WJ, Hodis HN, Pogoda JM, Crawford DW, Selzer RH, Liu C, et al. Reduction of carotid artery intima-media thickness with lipid lowering therapies: a comparison of two clinical trials [Abstract]. J Am Coll Cardiol. 1993;21(Suppl A):166A.
13. Furberg CD, Adams HP Jr, Applegate WB, Byington RP, Espeland MA, Hartwell T, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation. 1994;90:1679-88.
14. Grouse JR, Byington RP, Bond MG, Espeland MA, Craven TE, Sprinkle JW, et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II) Am J Cardiol. 1995;75:455-9.
15. Walldius G, Erikson U, Olsson AG, Bergstrand L, Hådell K, Johansson J, et al. The effect of probucol on femoral atherosclerosis the Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol. 1994;74:875-83.
16. Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis. 1987;68:19-25.
17. Gordon BR, Daal SD. Advances in LDL-apheresis for the treatment of severe hyper-cholesterolemia. Curr Opin Lipidol. 1994;5:69-73
18. Yamamoto A. Regression of atherosclerosis in humans by lowering serum cholesterol. Atherosclerosis. 1991;89:1-10.
19. Tatami R, Inoue N, Itoh H, Kishino B, Koga K, Nakashima Y, et al. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. The LARS Investigators. Atherosclerosis. 1992;95:1-13.
20. Thompson GR, Maher VM, Matthews S, Kitano Y, Neuwirth C, Shortt MB, et al. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet. 1995;345:811-6.
21. Yamamoto K, Nakashima Y, Koga N, Sasaki J, Takagi S, Kobori S, et al. A 5-year follow-up of low-density lipoprotein apheresis in patients with familial hypercholesterolemia: a multicenter study Nutrition and Metabolism in Cardiovascular Disease. 1995;5:181-8.
22. Kroon AA, Aengevaeren WR, van der Werf T, Uijen GJ, Reiber JH, Bruschke AV, et al. The LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation. 1996;93:1826-35.
23. Stalenhoef AF, Mol MJ, Stuyt PM. Efficacy and tolerability of simvastatin (MK-733). Am J Med. 1989;4A:39S-43S.
24. Wikstrand J, Wiklund O. Frontiers in cardiovascular science. Quantitative measurements of atherosclerotic manifestations in humans. Arterioscler Thromb. 1992;12:114-9.
25. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993;88:837-45.
26. Kohler TR, Nance DR, Cramer MM, Vandenburghe N, Strandness DE Jr. Duplex scanning for diagnosis of aortoiliac and femoropopliteal disease: a prospective study. Circulation. 1987;76:1074-80.
27. Legemate DA, Teeuwen C, Hoeneveld H, Ackerstaff RG, Eikelboom BC. Spectral analysis criteria in duplex scanning of aortoiliac and femoropopliteal arterial disease. Ultrasound Med Biol. 1991;17:769-76.
28. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-406.
29. Salonen R, Haapanen A, Salonen JT. Measurement of intima-media thickness of common carotid arteries with high-resolution B-mode ultrasonography: inter- and intra-observer variability. Ultrasound Med Biol. 1991;17:225-30.
30. Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, et al. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. Circulation. 1990;82:1230-42.
31. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 1991;134:250-6.
32. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb. 1993;13:1404-11.
33. Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study. Arterioscler Thromb. 1994;14:1885-91.
34. Salonen R, Tervahauta M, Salonen JT, Pekkanen J, Nissinen A, Karvonen MJ. Ultrasonographic manifestations of common carotid atherosclerosis in elderly eastern Finnish men. Prevalence and associations with cardiovascular diseases and risk factors. Arterioscler Thromb. 1994;14:1631-40.
35. Kroon AA, Stalenhoef AF. Effect of aggressive versus conventional lipid-lowering treatment on coronary and peripheral atherosclerosis: design and baseline characteristics of the LDL-Apheresis Atherosclerosis Regression Study (LAARS). In: Bruschke AV, Reiber JH, Lie KI, Wellens HJ, eds Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis. London: Kluwer; 1996:193-202.
36. Demacker PN, Hijmans AG, Vos-Janssen HE, van 't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin Chem. 1980;26:1775-9.
37. Lopes-Virella MF, Virella G, Evans G, Malenkos SB, Colwell JA. Immunonephelometric assay of human apolipoprotein AI. Clin Chem. 1980;26:1205-8.
38. Apstein CS, Zilversmit DB, Lees RS, George PK. Effect of intensive plasmapheresis on the plasma cholesterol concentration with familial hypercholesterolemia. Atherosclerosis. 1978;31:105-15.
39. van Asten WN, Beijneveld WJ, Pieters BR, van Lier HJ, Wijn PF, Skotnicki SH. Assessment of aortoiliac obstructive disease by Doppler spectrum analysis of blood flow velocities in the common femoral artery at rest and during reactive hyperemia. Surgery. 1991;109:633-9.
40. Kroon AA, Ajubi N, van Asten WN, Stalenhoef AF. The prevalence of peripheral vascular disease in familial hypercholesterolaemia. J Intern Med. 1995;238:451-9.
41. Wong M, Edelstein J, Wollman J, Bond MG. Ultrasonic-pathological comparison of the human arterial wait. Verification of intima-media thickness. Arterioscler Thromb. 1993;13:482-6.
42. Furberg CD, Byington RP, Craven TE. Lessons learned from clinical trials with ultrasound end-points. J Intern Med. 1994;236:575-80.
43. Gordon BR, Kelsey SF, Bilheimer DW, Brown DC, Dau PC, Gotto AM Jr, et al. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Am J Cardiol. 1992;70:1010-6.
44. Homer D, Ingall TJ, Baker HL Jr, O'Fallon WM, Kottke BA, Whisnant JP. Serum lipids and lipoproteins are less powerful predictors of extracranial carotid artery atherosclerosis than are cigarette smoking and hypertension. Mayo Clin Proc. 1991;66:259-67.
45. Karnegis JN, Matts JP, Tuna N, Hunter D, Amplatz K. Correlation of coronary and peripheral arterial stenosis. The POSCH Group. Atherosclerosis. 1992;92:25-30.
46. Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE, et al. Associations of lipoprotein cholesterols, apolipoproteins A-1 and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 1994;14:1098-104
47. Salonen JT, Salonen R. Risk factors for carotid and femoral atherosclerosis in hypercholesterolaemic men. J Intern Med. 1994;236:561-6.
48. Widmann MD, Sumpio BE. Lipoprotein (a): a risk factor for peripheral vascular disease Ann Vasc Surg. 1993;7:446-51.
49. Koizumi J, Koizumi I, Uno Y, Inazu A, Kajinami K, Haraki T, et al. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia. Atherosclerosis. 1993;100:65-74.
50. Jürgens G, Ashy A, Zenker G. Raised serum lipoprotein during treatment with lovastatin [Letter]. Lancet. 1989;1:911-2.
51. Keller C. LDL-apheresis: results of longterm treatment and vascular outcome. Atherosclerosis. 1991;86:1-8.
52. Knisel W, Di Nicuolo A, Pfohl M, Müller H, Risler T, Eggstein M, et al. Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Intern Med. 1993;234:479-87.
53. Rubba P, Iannuzzi A, Postiglione A, Scarpato N, Montefusco S, Gnasso A, et al. Hemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia. Circulation. 1990;81:610-7.
54. Pfohl M, Naoumova RP, Klass C, Knisel W, Jakober B, Risler T, et al. Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy. J Lipid Res. 1994;35:1946-55.